A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
Clinical trial NCT05115006 · COMPLETED
Trial details
- NCT number
- NCT05115006
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-07
- Primary completion
- 2022-06-02
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.